Filius Bart (CIK 2115417) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-21). Recent activity: Buy PRQR (150,000 shares), Buy PRQR (150,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-21 | ProQR Therapeutics N.V. (PRQR) | Director | Buy | 150,000 | $257,925 |
| 2026-06-30 | ProQR Therapeutics N.V. (PRQR) | Director | Buy | 150,000 | $231,000 |
Source: SEC Form 4 filings · as of 2026-07-21